Oman vs Sur: New cases tested for RR-/MDR-TB
Oman
100.0%
in 2024
Sur
97.0%
in 2024
Oman rank
1st
Sur rank
1st
New cases tested for RR-/MDR-TB over time
- Oman
- Sur
How they compare
Oman currently reports 100.0% against 97.0% in Sur, a difference of 3.0%.
The two have swapped places 8 times across 18 shared years of data; in 2005 it was Oman ahead.
Oman ranks 1st and Sur ranks 1st of 192 countries.
Across the 3 decades both report, Oman averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Oman | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 69.3% | 32.2% | 37.1% | Oman |
| 2010s | 95.9% | 62.2% | 33.7% | Oman |
| 2020s | 91.2% | 97.2% | 6.0% | Sur |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Oman or Sur?
- Oman, at 100.0% against 97.0% in Sur as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Oman and Sur?
- 3.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Sur?
- 18 years are reported by both, from 2005 to 2024.
- How do Oman and Sur rank globally for new cases tested for rr-/mdr-tb?
- Oman ranks 1st and Sur ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.